ABSTRACT: CARDIOAI AI DIAGNOSTIC AND TREATMENT SYSTEM

ABSTRACT

Title: Transforming Cardiovascular Disease Diagnosis and Treatment through Advanced AI Systems:

Cardiovascular disease (CVD), particularly myocardial infarction (MI), remains a leading cause of morbidity and mortality worldwide. Current diagnostic and treatment approaches often rely on single-modality assessments, resulting in suboptimal, generalized care that fails to address the complex, multifactorial nature of CVD. This project proposes the development of an innovative AI diagnostic and treatment system that integrates advanced artificial intelligence (AI) and machine learning (ML) algorithms, multi-sensing technology, genomic sequencing, multi-imaging integration, and autoencoders to enhance the accuracy and personalization of cardiovascular care.

The intellectual merit of this project lies in its ability to leverage novel AI techniques to analyze diverse datasets, including real-time physiological measurements, genetic information, ECG data and multi-imaging data. By employing deep learning and autoencoders, our system will not only optimize feature extraction and reduce dimensionality but also enable continuous monitoring of patients, resulting in timely and informed clinical decisions. This comprehensive approach will facilitate the identification of subtle patterns that traditional methods may overlook, leading to improved diagnostic accuracy and personalized treatment plans tailored to individual patient profiles.

The broader impact of this project extends beyond enhanced diagnostic capabilities. By integrating cutting-edge technologies, we aim to establish a scalable framework that can be adapted for various healthcare settings, ultimately improving patient outcomes and reducing the burden of CVD. Furthermore, our system promotes health equity by ensuring that personalized treatment strategies are accessible to diverse patient populations, thereby addressing disparities in cardiovascular care. Through this innovative technology, we seek to pave the way for a new era of precision medicine in cardiovascular health, fostering innovation that can be translated into real-world applications and ultimately saving lives.